Integrated Multilevel Experimental Assessment of Heart Support Oil Phytocompounds Across Molecular Motor Proteins, β2-Adrenergic Signalling, Mitochondrial Stress, and Cardiomyocyte Contractile Function

Heart Support Oil (HSO) is a multicomponent botanical formulation derived from Juglans regia, Lycium barbarum, Citrus × paradisi, and Origanum vulgare. This study addressed two related but analytically distinct questions: whether selected analytically detectable HSO phytocompounds show direct target-engagement signals at molecular motor proteins and the β2-adrenergic receptor (β2-AR), and whether the complete standardised formulation modifies oxidative- and adrenergic-stress phenotypes in cardiomyocyte models. Selected constituents were examined by target-specific biophysical/biochemical assays, whereas complete HSO was evaluated in human induced-pluripotent-stem-cell-derived cardiomyocytes and AC16 cells using membrane-injury, oxidative-stress, mitochondrial, calcium-transient, electrophysiological, contractile, qRT-PCR, and immunoblot endpoints. HSO produced concentration-dependent improvements under the tested stress conditions. At 20 µg/mL, CellTiter-Glo signal reached 91.0 ± 1.4% of control, reactive oxygen species decreased to 1.29 ± 0.04-fold, and mitochondrial membrane potential and cellular ATP recovered to 89.8 ± 1.6% and 87.3 ± 1.3% of control, respectively. HSO also moderated isoproterenol-associated abnormalities in cAMP signalling, beat rate, calcium handling, and contractility and shifted stress-, inflammatory-, apoptotic-, and antioxidant-response markers toward control values. Direct target assays demonstrated measurable binding and enzymatic changes for selected constituents, but these molecular observations were not interpreted as proving that the same targets caused the formulation-level cardiomyocyte phenotype. The findings support further independently replicated, pharmacokinetic, mechanistic loss-of-function, and in vivo studies; they do not establish a unique causal mechanism or clinical efficacy.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-13
DOI
https://doi.org/10.3390/ijms272210176
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated Multilevel Experimental Assessment of Heart Support Oil Phytocompounds Across Molecular Motor Proteins, β2-Adrenergic Signalling, Mitochondrial Stress, and Cardiomyocyte Contractile Function

Jing Zhao, Katarina Dunjić, Marija Đunjić, Stefano Turini et al.
2 links
International Journal of Molecular Sciences
Traditional Chinese Medicine Analysis
article

Integrated Multilevel Experimental Assessment of Heart Support Oil Phytocompounds Across Molecular Motor Proteins, β2-Adrenergic Signalling, Mitochondrial Stress, and Cardiomyocyte Contractile Function

Jing Zhao, Katarina Dunjić, Marija Đunjić, Stefano Turini, T. Novaković, Momir Dunjić, Lazar Nejković, Ljiljana Sulovic
article en

Abstract

Heart Support Oil (HSO) is a multicomponent botanical formulation derived from Juglans regia, Lycium barbarum, Citrus × paradisi, and Origanum vulgare. This study addressed two related but analytically distinct questions: whether selected analytically detectable HSO phytocompounds show direct target-engagement signals at molecular motor proteins and the β2-adrenergic receptor (β2-AR), and whether the complete standardised formulation modifies oxidative- and adrenergic-stress phenotypes in cardiomyocyte models. Selected constituents were examined by target-specific biophysical/biochemical assays, whereas complete HSO was evaluated in human induced-pluripotent-stem-cell-derived cardiomyocytes and AC16 cells using membrane-injury, oxidative-stress, mitochondrial, calcium-transient, electrophysiological, contractile, qRT-PCR, and immunoblot endpoints. HSO produced concentration-dependent improvements under the tested stress conditions. At 20 µg/mL, CellTiter-Glo signal reached 91.0 ± 1.4% of control, reactive oxygen species decreased to 1.29 ± 0.04-fold, and mitochondrial membrane potential and cellular ATP recovered to 89.8 ± 1.6% and 87.3 ± 1.3% of control, respectively. HSO also moderated isoproterenol-associated abnormalities in cAMP signalling, beat rate, calcium handling, and contractility and shifted stress-, inflammatory-, apoptotic-, and antioxidant-response markers toward control values. Direct target assays demonstrated measurable binding and enzymatic changes for selected constituents, but these molecular observations were not interpreted as proving that the same targets caused the formulation-level cardiomyocyte phenotype. The findings support further independently replicated, pharmacokinetic, mechanistic loss-of-function, and in vivo studies; they do not establish a unique causal mechanism or clinical efficacy.

International Journal of Molecular SciencesVol. 27(22)
University of Novi Sad (RS), Alma Mater Europaea (SI), University of Belgrade (RS), China Academy of Chinese Medical Sciences (CN), University of Priština - Kosovska Mitrovica (XK), Institute for Medical Research (RS), University of Prishtina (XK)
Good health and well-being
Traditional Chinese Medicine Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon